Intellia Therapeutics (NTLA)'s 30-day implied volatility (IV30) was 69.2% at the close on November 16, 2026, down from 78.9% the day before, against a 52-week range of 58.3% to 100.3%. Its 20-day historical volatility was 85.9%.
Data as of November 16, 2026.